UniProt ID | KTHY_HUMAN | |
---|---|---|
UniProt AC | P23919 | |
Protein Name | Thymidylate kinase | |
Gene Name | DTYMK | |
Organism | Homo sapiens (Human). | |
Sequence Length | 212 | |
Subcellular Localization | ||
Protein Description | Catalyzes the conversion of dTMP to dTDP.. | |
Protein Sequence | MAARRGALIVLEGVDRAGKSTQSRKLVEALCAAGHRAELLRFPERSTEIGKLLSSYLQKKSDVEDHSVHLLFSANRWEQVPLIKEKLSQGVTLVVDRYAFSGVAFTGAKENFSLDWCKQPDVGLPKPDLVLFLQLQLADAAKRGAFGHERYENGAFQERALRCFHQLMKDTTLNWKMVDASKSIEAVHEDIRVLSEDAIRTATEKPLGELWK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAARRGALI ------CCCCCCCEE | 15.07 | 19413330 | |
25 | Ubiquitination | GKSTQSRKLVEALCA CCCHHHHHHHHHHHH | 63.23 | - | |
25 | Acetylation | GKSTQSRKLVEALCA CCCHHHHHHHHHHHH | 63.23 | 26051181 | |
31 | Glutathionylation | RKLVEALCAAGHRAE HHHHHHHHHHCCHHH | 2.92 | 22555962 | |
31 | S-nitrosylation | RKLVEALCAAGHRAE HHHHHHHHHHCCHHH | 2.92 | 22178444 | |
31 | S-nitrosocysteine | RKLVEALCAAGHRAE HHHHHHHHHHCCHHH | 2.92 | - | |
41 | Methylation | GHRAELLRFPERSTE CCHHHHCCCCHHHHH | 58.67 | - | |
51 | Ubiquitination | ERSTEIGKLLSSYLQ HHHHHHHHHHHHHHH | 52.49 | 21890473 | |
51 | Acetylation | ERSTEIGKLLSSYLQ HHHHHHHHHHHHHHH | 52.49 | 23236377 | |
51 | Ubiquitination | ERSTEIGKLLSSYLQ HHHHHHHHHHHHHHH | 52.49 | 21890473 | |
54 | Phosphorylation | TEIGKLLSSYLQKKS HHHHHHHHHHHHHCC | 27.63 | 28152594 | |
55 | Phosphorylation | EIGKLLSSYLQKKSD HHHHHHHHHHHHCCC | 29.81 | 21406692 | |
56 | Phosphorylation | IGKLLSSYLQKKSDV HHHHHHHHHHHCCCC | 15.13 | 21406692 | |
59 | Acetylation | LLSSYLQKKSDVEDH HHHHHHHHCCCCCCC | 52.21 | 25953088 | |
59 | Malonylation | LLSSYLQKKSDVEDH HHHHHHHHCCCCCCC | 52.21 | 26320211 | |
59 | Ubiquitination | LLSSYLQKKSDVEDH HHHHHHHHCCCCCCC | 52.21 | - | |
60 | Malonylation | LSSYLQKKSDVEDHS HHHHHHHCCCCCCCC | 38.64 | 26320211 | |
84 | Ubiquitination | WEQVPLIKEKLSQGV HHCCCHHHHHHHCCC | 57.38 | - | |
88 | Phosphorylation | PLIKEKLSQGVTLVV CHHHHHHHCCCEEEE | 35.64 | 22210691 | |
92 | Phosphorylation | EKLSQGVTLVVDRYA HHHHCCCEEEEEEEE | 22.21 | 20068231 | |
106 | Phosphorylation | AFSGVAFTGAKENFS ECCCEEECCCCCCCC | 26.88 | 22210691 | |
118 | Ubiquitination | NFSLDWCKQPDVGLP CCCCCCCCCCCCCCC | 61.69 | - | |
143 | Methylation | QLADAAKRGAFGHER HHHHHHHHCCCCCHH | 36.62 | - | |
151 | Phosphorylation | GAFGHERYENGAFQE CCCCCHHHHCCHHHH | 15.68 | 27642862 | |
169 | Acetylation | RCFHQLMKDTTLNWK HHHHHHHCCCCCCCE | 61.59 | 19608861 | |
169 | Succinylation | RCFHQLMKDTTLNWK HHHHHHHCCCCCCCE | 61.59 | 23954790 | |
176 | Ubiquitination | KDTTLNWKMVDASKS CCCCCCCEEECCHHH | 28.15 | - | |
176 | 2-Hydroxyisobutyrylation | KDTTLNWKMVDASKS CCCCCCCEEECCHHH | 28.15 | - | |
182 | Ubiquitination | WKMVDASKSIEAVHE CEEECCHHHHHHHHH | 58.11 | - | |
182 | 2-Hydroxyisobutyrylation | WKMVDASKSIEAVHE CEEECCHHHHHHHHH | 58.11 | - | |
182 | Acetylation | WKMVDASKSIEAVHE CEEECCHHHHHHHHH | 58.11 | 25038526 | |
183 | Phosphorylation | KMVDASKSIEAVHED EEECCHHHHHHHHHH | 24.14 | 30624053 | |
192 | Methylation | EAVHEDIRVLSEDAI HHHHHHHHHHCHHHH | 35.33 | - | |
195 | Phosphorylation | HEDIRVLSEDAIRTA HHHHHHHCHHHHHHH | 30.49 | - | |
201 | Phosphorylation | LSEDAIRTATEKPLG HCHHHHHHHCCCCHH | 31.64 | - | |
205 | Ubiquitination | AIRTATEKPLGELWK HHHHHCCCCHHHHCC | 40.98 | - | |
205 | Malonylation | AIRTATEKPLGELWK HHHHHCCCCHHHHCC | 40.98 | 30639696 | |
212 | Acetylation | KPLGELWK------- CCHHHHCC------- | 64.19 | 30588319 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KTHY_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KTHY_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DHB7_HUMAN | HSD17B7 | physical | 21988832 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-169, AND MASS SPECTROMETRY. |